Annexes to COM(2023)122 - Specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland

Please note

This page contains a limited version of this dossier in the EU Monitor.

dossier COM(2023)122 - Specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland.
document COM(2023)122 EN
date June 14, 2023
Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community (OJ L 29, 31.1.2020, p. 1).
(10) Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, p. 67).
(11)

   Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (OJ L 136, 30.4.2004, p. 1).

(12) Commission Delegated Regulation (EU) 2016/161 of 2 October 2015 supplementing Directive 2001/83/EC of the European Parliament and of the Council by laying down detailed rules for the safety features appearing on the packaging of medicinal products for human use ( OJ L 32, 9.2.2016, p. 1).